RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Larimar Therapeutics ROCE 2024

Larimar Therapeutics ROCE

-0.51

Larimar Therapeutics Dividend yield

Ticker

LRMR

ISIN

US5171251003

WKN

A2P5PP

In 2024, Larimar Therapeutics's return on capital employed (ROCE) was -0.51, a 55.13% increase from the -0.33 ROCE in the previous year.

Larimar Therapeutics Aktienanalyse

What does Larimar Therapeutics do?

Larimar Therapeutics Inc is a US biotechnology company focused on developing therapies for rare genetic diseases. It was founded in 2018 and is based in Philadelphia, Pennsylvania. The company's mission is to accelerate the development of therapies for patients with rare genetic diseases through collaboration with academic researchers, patient organizations, and industry partners. They are active in various therapeutic areas, including neurological diseases, genetic metabolic disorders, and rare inherited diseases, with a diverse portfolio of drug candidates in different stages of clinical development. Their main focus is on developing therapies for Friedreich's ataxia, a rare neurological disease, and other neurologic disorders. They are also working on therapies for rare genetic metabolic disorders such as PKU and HFI. Larimar Therapeutics aims to improve the quality of life for patients with rare inherited diseases and adopts an innovative and patient-centered approach to their drug development. Collaborations and partnerships are integral to their strategy in order to make faster progress in the treatment of these often severe diseases. Larimar Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Larimar Therapeutics's Return on Capital Employed (ROCE)

Larimar Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Larimar Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Larimar Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Larimar Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Larimar Therapeutics Stock

What is the ROCE (Return on Capital Employed) of Larimar Therapeutics this year?

The ROCE of Larimar Therapeutics is -0.51 undefined this year.

How has the ROCE (Return on Capital Employed) of Larimar Therapeutics developed compared to the previous year?

The ROCE of Larimar Therapeutics has increased by 55.13% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Larimar Therapeutics?

A high Return on Capital Employed (ROCE) indicates that Larimar Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Larimar Therapeutics?

A low ROCE (Return on Capital Employed) can indicate that Larimar Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Larimar Therapeutics impact the company?

An increase in the ROCE of Larimar Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Larimar Therapeutics affect the company?

A decrease in ROCE of Larimar Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Larimar Therapeutics?

Some factors that can affect Larimar Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Larimar Therapeutics so important for investors?

The ROCE of Larimar Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Larimar Therapeutics take to improve the ROCE?

To improve the ROCE, Larimar Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Larimar Therapeutics pay?

Over the past 12 months, Larimar Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Larimar Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Larimar Therapeutics?

The current dividend yield of Larimar Therapeutics is .

When does Larimar Therapeutics pay dividends?

Larimar Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Larimar Therapeutics?

Larimar Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Larimar Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Larimar Therapeutics located?

Larimar Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Larimar Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Larimar Therapeutics from 4/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Larimar Therapeutics pay the last dividend?

The last dividend was paid out on 4/29/2024.

What was the dividend of Larimar Therapeutics in the year 2023?

In the year 2023, Larimar Therapeutics distributed 0 USD as dividends.

In which currency does Larimar Therapeutics pay out the dividend?

The dividends of Larimar Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Larimar Therapeutics

Our stock analysis for Larimar Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Larimar Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.